HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

6- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamine

has antineoplastic activity; structure in first source
Also Known As:
6-chloro-4MDMPA; BIIB021; CNF 2024; CNF-2024; CNF2024
Networked: 15 relevant articles (1 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Lundgren, Karen: 4 articles (03/2010 - 04/2009)
2. Zhang, Hong: 3 articles (03/2010 - 04/2009)
3. Burrows, Francis: 2 articles (03/2010 - 03/2010)
4. Neely, Laura: 2 articles (03/2010 - 04/2009)
5. Timple, Noel: 2 articles (03/2010 - 04/2009)
6. Burrows, Francis J: 2 articles (08/2009 - 04/2009)
7. Takeda, Tadashi: 1 article (01/2015)
8. Ito, Yoshinori: 1 article (01/2015)
9. Kimura, Hiroshi: 1 article (01/2015)
10. Goshima, Fumi: 1 article (01/2015)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Squamous Cell Carcinoma (Epidermoid Carcinoma)
4. Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
5. Lymphoma (Lymphomas)

Related Drugs and Biologics

1. 6- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamine
2. STA 9090
3. 17-(allylamino)-17-demethoxygeldanamycin (17AAG)
4. Biological Markers (Surrogate Marker)
5. Heat-Shock Proteins (Heat-Shock Protein)
6. Proteins (Proteins, Gene)
7. NK Cell Lectin-Like Receptor Subfamily K
8. P-Glycoprotein
9. HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
10. Annexin A5

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Radiotherapy
3. Oral Administration